Gland Pharma Schedules Institutional Investor and Analyst Meetings in Sep'26
Gland Pharma Ltd 路 Intimation 路 10 Sept 2026, 11:14 pm
Gland Pharma Schedules Institutional Investor and Analyst Meetings in Sep'26 Gland Pharma Limited announced its schedule of institutional investor and analyst interactions under SEBI LODR Regulations. The company will conduct one-on-one meetings with East Bridge Capital on 16th Sep'26, followed by sessions with IIFL Capital and Antique Broking on 17th Sep'26. Additionally, Gland Pharma is scheduled to participate in a group meeting organized by Nomura on 25th Sep'26. All scheduled interactions remain subject to change based on exigencies from either the investors, analysts, or the company.
Original exchange filing (PDF)
More announcements from Gland Pharma Ltd
- Schedule of Investor Meet Intimation 路 17 Nov 2026
- Allotment of 3739 Equity Shares on exercise of ESOPs 路 16 Nov 2026
- Grant of Options to Purchase Securities 路 16 Nov 2026
- Q2FY27 Earnings Call Transcript 路 12 Nov 2026
- Gland Pharma Limited has issued Corporate Guarantee on behalf of Phixen SAS, wholly owned step down subsidiary of the Company 路 12 Nov 2026
- Appointment of Mr. Xiao Le as Chief Investment Officer at Gland Pharma International Pte. Ltd, wholly owned subsidiary of Gland Pharma Limited, effective November 09, 2026 路 09 Nov 2026
- Q2FY27 Earnings Call Recording 路 07 Nov 2026
- Q2Fy27 Investors presentation 路 06 Nov 2026
